Nakagawa H, Kichikawa K, Takayama K, Sakamoto M, Wada T, Taoka T, Fukusumi A, Iwasaki S, Uchida H, Sakaki T. Palmaz stent deployment for subclavian and brachiocephalic arterial occlusive disease. Factors predictive of restenosis.
Interv Neuroradiol 2001;
7:49-52. [PMID:
20663377 DOI:
10.1177/15910199010070s106]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2001] [Accepted: 09/15/2001] [Indexed: 11/17/2022] Open
Abstract
SUMMARY
Palmaz stent deployment is a useful method for subclavian and brachiocephalic arterial occlusive disease. We evaluated restenosis or intimal thickening after Palmaz stent deployment for nine lesions of subclavian or brachiocephalic arterial occlusive disease focusing on stent diameter, atheroma thickness near the stent, and degree of coverage for the lesion. Follow up DSA and IVUS at 5-14 months (mean 9) after therapy showed no significant changes in the size or shape of the stent itself There were two lesions of thin in-stent intimal hyperplasia and five lesions of thick hyperplasia. There was no close relationship between intimal hyperplasia and stent diameter or atheroma size (relative thickness). There was some relationship between the degree of coverage of the lesion by the stent and degree of intimal hyperplasia, but to determine statistical significance, accumulation of a greater number of cases is necessary.
Collapse